{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:22:57Z","timestamp":1792905777381,"version":"4.5.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,3,27]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Tet2 is a tumor suppressor in B cells. Loss of Tet2 in B cells leads to age-dependent transformation that requires AID.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017014118","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T12:00:10Z","timestamp":1522065610000},"page":"703-714","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":58,"title":["B-cell tumor development in Tet2-deficient mice"],"prefix":"10.1182","volume":"2","author":[{"given":"Enguerran","family":"Mouly","sequence":"first","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-1081","authenticated-orcid":false,"given":"Hussein","family":"Ghamlouch","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Della-Valle","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurianne","family":"Scourzic","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Quivoron","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Roos-Weil","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Pawlikowska","sequence":"additional","affiliation":[{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Centre National de la Recherche Scientifique (CNRS), UMR8200, Institut Gustave Roussy, Villejuif, France;"},{"name":"Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Saada","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u2019Boyba K.","family":"Diop","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile K.","family":"Lopez","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Fontenay","sequence":"additional","affiliation":[{"name":"D\u00e9partement D\u00e9veloppement, Reproduction, Cancer, Institut Cochin, INSERM U1016, CNRS UMR8104, Universit\u00e9 Paris Descartes, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Dessen","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo P.","family":"Touw","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mercher","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Aoufouchi","sequence":"additional","affiliation":[{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Centre National de la Recherche Scientifique (CNRS), UMR8200, Institut Gustave Roussy, Villejuif, France;"},{"name":"Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier A.","family":"Bernard","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR)1170, Institut Gustave Roussy, Villejuif, France;"},{"name":"Institut Gustave Roussy, Villejuif, France;"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris-Sud, INSERM, Institut Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France;"},{"name":"Equipe Labellis\u00e9e, Ligue Nationale Contre le Cancer, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,3,26]]},"reference":[{"issue":"8","key":"2019111618464382200_B1","doi-asserted-by":"crossref","first-page":"e42080","DOI":"10.1371\/journal.pone.0042080","article-title":"Aging of the microenvironment influences clonality in hematopoiesis","volume":"7","author":"Vas","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"2019111618464382200_B2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.stem.2012.04.007","article-title":"Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation","volume":"10","author":"Florian","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"50","key":"2019111618464382200_B3","doi-asserted-by":"crossref","first-page":"20012","DOI":"10.1073\/pnas.1116110108","article-title":"Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age","volume":"108","author":"Pang","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"2019111618464382200_B4","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1182\/blood-2011-12-376749","article-title":"Stem cell heterogeneity: implications for aging and regenerative medicine","volume":"119","author":"Muller-Sieburg","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111618464382200_B5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2019111618464382200_B6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"issue":"7","key":"2019111618464382200_B7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.391","article-title":"Acquired mutations in TET2 are common in myelodysplastic syndromes","volume":"41","author":"Langemeijer","year":"2009","journal-title":"Nat Genet"},{"issue":"1","key":"2019111618464382200_B8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"issue":"22","key":"2019111618464382200_B9","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111618464382200_B10","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3324\/haematol.2013.088740","article-title":"Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma","volume":"98","author":"Asmar","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"2019111618464382200_B11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"2019111618464382200_B12","doi-asserted-by":"crossref","first-page":"e18290","DOI":"10.7554\/eLife.18290","article-title":"Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility","volume":"5","author":"Lio","year":"2016","journal-title":"eLife"},{"issue":"6","key":"2019111618464382200_B13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/ni.3148","article-title":"TET1 is a tumor suppressor of hematopoietic malignancy","volume":"16","author":"Cimmino","year":"2015","journal-title":"Nat Immunol"},{"issue":"1","key":"2019111618464382200_B14","doi-asserted-by":"crossref","first-page":"34222","DOI":"10.1038\/srep34222","article-title":"Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice","volume":"6","author":"Haney","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"2019111618464382200_B15","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.celrep.2016.04.004","article-title":"Promoter hypomethylation and expression is conserved in mouse chronic lymphocytic leukemia induced by decreased or inactivated Dnmt3a","volume":"15","author":"Haney","year":"2016","journal-title":"Cell Reports"},{"issue":"5","key":"2019111618464382200_B16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ajh.24301","article-title":"Chronic lymphocytic leukemia: time to go past genomics?","volume":"91","author":"Roos-Weil","year":"2016","journal-title":"Am J Hematol"},{"issue":"9","key":"2019111618464382200_B17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.it.2015.07.003","article-title":"AID targeting: old mysteries and new challenges","volume":"36","author":"Chandra","year":"2015","journal-title":"Trends Immunol"},{"key":"2019111618464382200_B18","doi-asserted-by":"crossref","first-page":"15102","DOI":"10.1038\/ncomms15102","article-title":"Tet2 loss leads to hypermutagenicity in haematopoietic stem\/progenitor cells","volume":"8","author":"Pan","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"2019111618464382200_B19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","article-title":"Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation","volume":"20","author":"Moran-Crusio","year":"2011","journal-title":"Cancer Cell"},{"issue":"6","key":"2019111618464382200_B20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/nar\/25.6.1317","article-title":"B lymphocyte-specific, Cre-mediated mutagenesis in mice","volume":"25","author":"Rickert","year":"1997","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2019111618464382200_B21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"issue":"7","key":"2019111618464382200_B22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.20091927","article-title":"Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency","volume":"207","author":"Walter","year":"2010","journal-title":"J Exp Med"},{"issue":"Web server issue","key":"2019111618464382200_B23","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"Web server issue","key":"2019111618464382200_B24","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2019111618464382200_B25","first-page":"695","article-title":"IMGT\/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences","volume":"2011","author":"Giudicelli","year":"2011","journal-title":"Cold Spring Harb Protoc"},{"issue":"Database issue","key":"2019111618464382200_B26","doi-asserted-by":"crossref","first-page":"D1006","DOI":"10.1093\/nar\/gkn838","article-title":"IMGT, the international ImMunoGeneTics information system","volume":"37","author":"Lefranc","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2019111618464382200_B27","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","article-title":"Acquired initiating mutations in early hematopoietic cells of CLL patients","volume":"4","author":"Damm","year":"2014","journal-title":"Cancer Discov"},{"issue":"1","key":"2019111618464382200_B28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"issue":"31","key":"2019111618464382200_B29","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.1073\/pnas.0604564103","article-title":"B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia","volume":"103","author":"Yan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019111618464382200_B30","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.173.5.1213","article-title":"Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow","volume":"173","author":"Hardy","year":"1991","journal-title":"J Exp Med"},{"issue":"7354","key":"2019111618464382200_B31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"4","key":"2019111618464382200_B32","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111618464382200_B33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.dnarep.2014.11.006","article-title":"AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature","volume":"25","author":"Pettersen","year":"2015","journal-title":"DNA Repair (Amst)"},{"issue":"1","key":"2019111618464382200_B34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat Genet"},{"issue":"20","key":"2019111618464382200_B35","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2012-05-433540","article-title":"Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns","volume":"120","author":"Schuh","year":"2012","journal-title":"Blood"},{"issue":"26","key":"2019111618464382200_B36","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111618464382200_B37","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019111618464382200_B38","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2019111618464382200_B39","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"issue":"3","key":"2019111618464382200_B40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3727\/105221615X14181438356256","article-title":"The long journey of TCL1 transgenic mice: lessons learned in the last 15 years","volume":"16","author":"Pekarsky","year":"2015","journal-title":"Gene Expr"},{"issue":"10","key":"2019111618464382200_B41","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111618464382200_B42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4049\/jimmunol.1302570","article-title":"Modeling the clinical phenotype of BTK inhibition in the mature murine immune system","volume":"193","author":"Benson","year":"2014","journal-title":"J Immunol"},{"issue":"3","key":"2019111618464382200_B43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ni1036","article-title":"B cell receptor signal strength determines B cell fate","volume":"5","author":"Casola","year":"2004","journal-title":"Nat Immunol"},{"issue":"1","key":"2019111618464382200_B44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.2836","article-title":"Large conserved domains of low DNA methylation maintained by Dnmt3a","volume":"46","author":"Jeong","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"2019111618464382200_B45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.12239","article-title":"TET proteins and 5-methylcytosine oxidation in hematological cancers","volume":"263","author":"Ko","year":"2015","journal-title":"Immunol Rev"},{"issue":"8","key":"2019111618464382200_B46","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med"},{"issue":"24","key":"2019111618464382200_B47","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1182\/blood-2011-12-397588","article-title":"In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells","volume":"120","author":"Soucie","year":"2012","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/6\/703\/882788\/advances014118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/6\/703\/882788\/advances014118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T18:47:06Z","timestamp":1573930026000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/6\/703\/15801\/Bcell-tumor-development-in-Tet2deficient-mice"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,26]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,3,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017014118","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,26]]}}}